Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: GSK 10.595, AstraZeneca 15.288.
GSK vs AstraZeneca Net Worth and Market Cap
GSK (GSK) and AstraZeneca (AZN) are peers in Vaccines. GSK reported revenue of $10.6B as of Q2 2026, compared with $15.3B for AstraZeneca. AstraZeneca leads on revenue.
GSK's gross margin is 73.0% versus 82.5% for AstraZeneca. GSK's net margin is 5.2% versus 20.1% for AstraZeneca.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, GSK, AstraZeneca.| Metric | GSK | AstraZeneca |
|---|---|---|
| Market Cap | - | - |
| Revenue | $10.60B | $15.29B |
| Cost of Revenue | $2.85B | $2.68B |
| Gross Profit | $7.74B | $12.61B |
| Operating Income | $606.00M | $4.25B |
| Net Income | $548.00M | $3.08B |
| R&D Expense | $4.37B | $3.49B |
| Earnings Per Share | $0.28 | $1.97 |
| Gross Margin | 73.0% | 82.5% |
| Operating Margin | 5.7% | 27.8% |
| Net Profit Margin | 5.2% | 20.1% |
| Free Cash Flow | $2.78B | $1.82B |
| Cumulative Free Cash Flow | $157.21B | $120.67B |
| Operating Cash Flow | $3.19B | $3.36B |
| Cash & Equivalents | $3.89B | $7.56B |
Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.